levofloxacin - CISMeF

Preferred Label : levofloxacin;

MeSH definition : The L-isomer of Ofloxacin.;

MeSH synonym : ofloxacin, (S)-Isomer;

MeSH hyponym : quixin; levaquin; levofloxacin anhydrous; Anhydrous, Levofloxacin;

MeSH Related Number : 100986-85-4 (Levofloxacin); levofloxacin anhydrous; RIX4E89Y14;

Related CAS MeSH : RIX4E89Y14 (Levofloxacin anhydrous);

Wikipedia link : https://en.wikipedia.org/wiki/Levofloxacin;

Is substance : O;

UNII : 6GNT3Y5LMF;

InChIKey : SUIQUYDRLGGZOL-RCWTXCDDSA-N;

Details

Origin ID

D064704;

UMLS CUI

C0282386;

ATC code(s)
- levofloxacin [ATC Code]
ATC code(s)
- lansoprazole, amoxicillin and levofloxacin [ATC Code]
- levofloxacin [ATC Code]
- levofloxacin [ATC Code]
- levofloxacin and ornidazole [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Levofloxacin [ICD-11 Extension code]
Currated CISMeF NLP mapping
- Levofloxacin [NCIt concept]
- Levofloxacin (substance) [SNOMED CT concept]
- levoFLOXacin [LOINC component]
- levofloxacin [SNOMED Notion]
Pharmacological action(s)
- Cytochrome P-450 CYP1A2 Inhibitors [MeSH Descriptor]
- anti-bacterial agents [MeSH Descriptor]
- anti-infective agents, urinary [MeSH Descriptor]
- antineoplastic agents [MeSH Descriptor]
- topoisomerase II inhibitors [MeSH Descriptor]
Record concept(s)
- levaquin [MeSH concept]
- levofloxacin [MeSH concept]
- levofloxacin anhydrous [MeSH concept]
- quixin [MeSH concept]
Related MeSH Supplementary Concept(s)
- levofloxacin ethoxycarbonyl 1-ethyl hemiacetal ester [MeSH Supplementary Concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Levofloxacin [NCIt concept]
- Levofloxacin (substance) [SNOMED CT concept]
- Product containing levofloxacin (medicinal product) [SNOMED CT concept]
- levoFLOXacin [LOINC component]
- levofloxacin [ATC Code]
- levofloxacin [ATC Code]
- levofloxacin [SNOMED Notion]
Validated automatic mappings to BTNT
- Levofloxacin Anhydrous [NCIt concept]
- Levofloxacin anhydrous (substance) [SNOMED CT concept]
- levofloxacin [ATC Code]
- levofloxacin [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients